Literature DB >> 26690823

Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: A reappraisal.

M Reyes Oliver Perez1, Javier Magriñá2, Alvaro Tejerizo García3, Jesus Salvador Jiménez Lopez3.   

Abstract

At present, there is no effective screening of ovarian cancer. Primary prevention may be the only strategy to decrease the mortality from ovarian cancer, not only in women at high risk but also at low risk. Several recent studies have identified the distal fimbriae end of the fallopian tubes as primary precursor of High-grade serous carcinoma. Serous tubal intraepithelial carcinomas and occult invasive serous carcinomas have been identified in 2-17% of the fallopian tubes of BRCA1/2 positive women undergoing risk-reducing salpingo-oophorectomy. Removal of the fallopian tubes with ovarian preservation has been suggested as a reasonable strategy that could reduce the risk of developing ovarian carcinoma in both low and high-risk women. It has been proposed after childbearing in women at high risk to be followed by bilateral oophorectomy at a later date. Bilateral salpingectomy is also suggested for low risk women, at the time of other benign gynaecologic surgery as a primary preventive strategy. Some studies have shown a risk reduction of ovarian cancer in women with bilateral prophylactic salpingectomy. Current research regarding bilateral salpingoophorectomy as primary prevention approach of ovarian cancer is reviewed here. In addition, the potential use of bilateral salpingectomy as prevention approach of ovarian cancer is discussed.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BRCA 1 /2 mutation carriers; High grade serous carcinoma; Salpingectomy and ovarian cancer; Serous tubal intraepithelial carcinomas

Mesh:

Year:  2015        PMID: 26690823     DOI: 10.1016/j.suronc.2015.09.008

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  9 in total

1.  Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition.

Authors:  Gery Lamblin; Capucine Meysonnier; Stéphanie Moret; Béatrice Nadaud; Georges Mellier; Gautier Chene
Journal:  Int Urogynecol J       Date:  2017-07-13       Impact factor: 2.894

2.  Opportunistic Salpingectomy as an Ovarian Cancer Primary Prevention Strategy.

Authors:  Geetha Balsarkar
Journal:  J Obstet Gynaecol India       Date:  2017-05-11

Review 3.  Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

Authors:  Sinead H McEvoy; Stephanie Nougaret; Nadeem R Abu-Rustum; Hebert Alberto Vargas; Elizabeth A Sadowski; Christine O Menias; Fuki Shitano; Shinya Fujii; Ramon E Sosa; Joanna G Escalon; Evis Sala; Yulia Lakhman
Journal:  Abdom Radiol (NY)       Date:  2017-10

4.  Bioethical and Moral Perspectives in Human Reproductive Medicine.

Authors:  Joseph V Turner; Lucas A McLindon
Journal:  Linacre Q       Date:  2019-01-03

5.  Prophylactic salpingectomy and ovarian cancer: An evidence-based analysis.

Authors:  Tricia Dewi Anggraeni; Adly Nanda Al Fattah; Raymond Surya
Journal:  South Asian J Cancer       Date:  2018 Jan-Mar

Review 6.  Chlamydia trachomatis Genital Infections.

Authors:  Catherine M O'Connell; Morgan E Ferone
Journal:  Microb Cell       Date:  2016-09-05

Review 7.  Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.

Authors:  George U Eleje; Ahizechukwu C Eke; Ifeanyichukwu U Ezebialu; Joseph I Ikechebelu; Emmanuel O Ugwu; Onyinye O Okonkwo
Journal:  Cochrane Database Syst Rev       Date:  2018-08-24

Review 8.  Clinical implication for endometriosis associated with ovarian cancer.

Authors:  Pao-Ling Torng
Journal:  Gynecol Minim Invasive Ther       Date:  2017-08-30

9.  Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy: Assessment of Possible Complications and Histopathological p53-Signatures.

Authors:  Gautier Chene; Sarah Urvoas; Stéphanie Moret; Béatrice Nadaud; Annie Buenerd; Philippe Chabert; Georges Mellier; Gery Lamblin
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-06-25       Impact factor: 2.915

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.